The U.S. Food and Drug Administration (FDA) has approved a new liquid form of a medicine called valproic acid. This medicine is already well-known and used to treat certain types of epileptic seizures. It is also used to help prevent migraine headaches in adults. The approval means this established treatment is now available in an oral solution, which can be easier to swallow for some patients, including children or adults who have difficulty with pills.
This approval is for patients who have been diagnosed with specific seizure types, such as complex partial seizures or absence seizures. It can be used by itself or added to other seizure medicines. For preventing migraines, it is for adults where other treatments have not worked well. The main benefit is offering a different way to take a medicine that doctors have used for a long time.
It is important for patients to know there is a serious safety consideration with this medicine. The drug label carries strong warnings about significant risks of birth defects and developmental problems if taken during pregnancy. Because of these risks, doctors are advised to avoid using it in women who are pregnant or who could become pregnant, unless other treatments are not suitable.
If you or a loved one has epilepsy or migraines, this new formulation might be a topic to discuss with your healthcare provider. They can explain if this liquid form is appropriate for your specific situation, considering all the benefits and potential risks. Always talk to your doctor about any changes to your treatment.